Satiety After Eating Okra Flour Biscuits
Official title: Evaluating the Impact of Mature Okra Flour-Incorporated Biscuits (MOFB) on Perceived Satiety Through the Satiety Labeled Intensity Magnitude (SLIM) Scale and Metabolomic Approach
Run by Universiti Putra Malaysia · NCT07631663 · Data updated 2026-11-12
This study tests whether biscuits made with mature okra flour help young adults feel fuller and affect blood markers compared with standard biscuits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 39 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Universiti Putra Malaysia Academic / other |
| Locations | 1 site (Serdang, Selangor) |
| Status | Recruiting |
| Started | May 15, 2026 |
| Main results expected | June 25, 2026 |
| Study ends | June 25, 2026 |
| Registry record updated | June 8, 2026 |
| Trial ID | NCT07631663 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy young adults aged 18–39 with normal BMI who are non-smokers and not on medications affecting appetite or metabolism.
✕Probably not a fit
Individuals with chronic metabolic or cardiovascular conditions, those on hormonal or appetite-affecting medications, or pregnant/lactating women may not benefit or participate.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In a single-blind, randomized design, participants will consume either okra flour biscuits or standard biscuits on separate occasions. Throughout a 165-minute period, researchers will assess fullness using a visual scale and collect blood samples to analyze glucose, appetite hormones, and metabolic responses. Okra flour replaces 10% of wheat flour in the test biscuits, targeting satiety and metabolic effects while exploring potential sustainability benefits of using mature okra. The study focuses on healthy young adults aged 18–39 with normal BMI, excluding individuals with certain medications or conditions that could influence appetite or metabolism.
Why it matters
Potential benefit: If successful, the approach could offer a tasty way to modulate fullness and metabolic responses in healthy adults.
How similar studies have gone: Previous research has explored functional foods with altered satiety signals; this study uses a novel by-product ingredient (mature okra flour) in biscuits and includes metabolomic analyses.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Young adults aged between 18 and 39 years. * Normal Body Mass Index (BMI). Exclusion Criteria: * Smokers. * Pregnant or lactating women. * Individuals with daily medication prescriptions for chronic metabolic conditions, cardiovascular management, or hormonal regulation. * Use of daily medications/supplements that influence appetite regulation, metabolic signalling, or systemic metabolomic profiles, including: 1. Hormonal contraceptives, glucocorticoids, and oral/injectable anti-obesity medications (e.g., GLP-1 agonists). 2. Antihypertensives and lipid-lowering agents (statins). 3. Chronic Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). 4. Daily fibre supplements.
Where it's running
-
Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM)
Serdang, Selangor, Malaysia Recruiting
Study contacts
- Study coordinator: Chee Yee Tan
- Email: cheeyee721@gmail.com
- Phone: +60134904250
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Does Paracetamol Change Gut Hormones, Glucose Absorption, and Blood Sugar in Healthy Young Adults
This study tests whether taking paracetamol can influence gut hormone release and how the body absorbs glucose in healthy young adults.
-
Sustainable and inclusive alternative proteins for Mediterranean diets (CIPROMED)
This study tests whether breads and other Mediterranean foods made with alternative proteins (like cricket, spirulina, hemp, and legumes) change appetite, fullness, food choices, and metabolic markers in healthy adults and people who are overweight.
-
Adaptive ankle exoskeleton controller to personalize walking support
Researchers will test a real-time controller for a robotic ankle exoskeleton that learns how you walk and adds the right amount of help to make walking easier.
-
Recovery after stopping semaglutide: effects on weight, heart risk, and appetite
This trial will test whether gradually lowering semaglutide instead of stopping it suddenly changes weight, heart risk markers, and appetite hormones in adults with obesity who lost at least 10% of their weight on semaglutide.
-
Whey protein before meals to improve blood sugar in older adults with type 2 diabetes
This study will try giving people aged 75–90 with type 2 diabetes a whey protein supplement before meals to see if it improves daily blood sugar control compared with a protein-free placebo.
-
FluMist versus injected flu shot: immune responses in the nose and lungs of young adults
This trial will see if the FluMist nasal vaccine causes different immune responses in the blood, nose, and lungs than the standard injected flu shot in healthy adults aged 18 to 40.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.